Pemetrexed Dipotassium Patent Expiration

Pemetrexed Dipotassium was first introduced by Avyxa Holdings Llc in its drug Axtle on Jun 28, 2024.


Pemetrexed Dipotassium Patents

Given below is the list of patents protecting Pemetrexed Dipotassium, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Axtle US12721811 Jun 25, 2045 Avyxa Holdings



Pemetrexed Dipotassium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pemetrexed Dipotassium Generic API Manufacturers

Given below is the list of companies who have filed for Pemetrexed Dipotassium generic, along with the locations of their manufacturing plants worldwide.